We have 454 products in: Biochemicals >> Research Area >> Respiratory disease
Respiratory disease beginning with A - B |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Ca2+ ionophore Purity: > 99% | | ||
| Selective NaV1.8 channel blocker Purity: > 98% | | ||
| Endogenous neurotransmitter active at acetylcholine receptors | | ||
| Endogenous P1 receptor agonist Purity: > 99% | | ||
| Second messenger. PKA activator. Purity: > 98% | | ||
| M2 antagonist Purity: > 99% | | ||
| Selective EGF receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| Ca2+ channel blocker (P and Q type) Purity: > 95% | | ||
| Microtubule depolymerizing agent; affects tubulin dynamics Purity: > 98% | | ||
| Fluorescent β2 adrenoceptor antagonist Purity: > 97% | | ||
| Potent cyclin-dependent kinase (CDK) and GSK-3β inhibitor Purity: > 99% | | ||
| Highly selective CXCR4 antagonist Purity: > 99% | | ||
| Broad spectrum cytoprotective agent; inactive prodrug of WR-1065 Purity: > 98% | | ||
| eNaC blocker Purity: > 99% | | ||
| NOS inhibitor Purity: > 98% | | ||
| Fluorescent H2 antagonist Purity: > 97% | | ||
| K+ channel blocker Purity: > 99% | | ||
| Broad-spectrum ion channel blocker. Antiarrhythmic agent. Purity: > 98% | | ||
| β-lactam antibiotic Purity: > 99% | | ||
| Amyloid β protein fragment. Implicated in Alzheimer's disease. Purity: > 95% | | ||
| Predominant amyloid-β protein fragment Purity: > 95% | | ||
| Highly toxic amyloid β protein fragment Purity: > 95% | | ||
| Inactive control for Amyloid β (1-42) ( Purity: > 95% | | ||
| Amyloidogenic peptide Purity: > 97% | | ||
| Toxic amyloid β peptide fragment Purity: > 95% | | ||
| Amyloidogenic peptide Purity: > 95% | | ||
| Inactive control for Amyloid β (1-40) ( Purity: > 95% | | ||
| Potent anti-inflammatory agent Purity: > 99% | | ||
| Vasoconstrictor peptide Purity: > 95% | | ||
| Protein synthesis inhibitor Purity: > 98% | | ||
| Blocker of small conductance Ca2+-activated K+ channels Purity: > 95% | | ||
| Ca2+ release modulator Purity: > 98% | | ||
| Anticancer agent Purity: > 98% | | ||
| M2 antagonist Purity: > 99% | | ||
| Muscarinic receptor agonist Purity: > 99% | | ||
| Precursor to nitric oxide synthesis Purity: > 99% | | ||
| Antimalarial compound Purity: > 99% | | ||
| Calcineurin/PP2B inhibitor. Immunosuppressant and antifungal activity. Purity: > 98% | | ||
| Ascorbic acid derivative Purity: > 99% | | ||
| Multiple receptor antagonist. Anti-psychotic agent. Purity: > 99% | | ||
| β1 adrenoceptor antagonist Purity: > 99% | | ||
| Selective β1 adrenoceptor antagonist Purity: > 98% | | ||
| Selective α2 adrenergic receptor antagonist Purity: > 99% | | ||
| PAR4 agonist peptide Purity: > 95% | | ||
| Flavonoid. Lipoxygenase inhibitor. Purity: > 98% | | ||
| SNSR agonist Purity: > 95% | | ||
| Selective Ca2+ chelator. Analogue of BAPTA. Purity: > 98% | | ||
| Selective Ca2+ chelator Purity: > 98% | | ||
| DNA alkylating agent Purity: > 99% | | ||
| Potent glucocorticoid; immunomodulator Purity: > 98% | | ||
| Muscarinic receptor agonist Purity: > 98% | | ||
| Anticancer agent. TGR5 agonist. | | ||
| Potent, selective, reversible GSK3 inhibitor; cell-permeable Purity: > 98% | | ||
| Apoptotic anti-cancer, anti-inflammatory and anti-oxidant curcuminoid Purity: > 98% | | ||
| Selective β1 antagonist Purity: > 99% | | ||
| Broad spectrum nucleoside antibiotic Purity: > 98% | | ||
| Potent, selective, inhibitor of myosin II Purity: > 98% | | ||
| Selective myosin II ATPase activity inhibitor Purity: > 99% | | ||
| Potent Cdk5/p25 and Cdk2 inhibitor Purity: > 98% | | ||
| 5-HT1A partial agonist. α-adrenoceptor antagonist. Purity: > 99% | | ||
| Non-selective, potent adrenoceptor antagonist Purity: > 99% | | ||
| Potent, selective ETA receptor antagonist Purity: > 95% | | ||
| Bradykinin receptor agonist Purity: > 98% | | ||
| Inihibitor of ADP-ribosylation factor Purity: > 99% | | ||
| Positive allosteric modulator at M1 receptors. Purity: > 98% | | ||
| Potent non-selective β adrenoceptor antagonist Purity: > 99% | | ||
| Non-selective DAT/NET inhibitor Purity: > 98% | | ||
| Non-selective myosin ATPase inhibitor | |